# A Brief Progress in Methods for Deciphering Protein–Protein Interaction Networks

**Authors:** Xiaohan Yang, Wenming Cui, Liefeng Wang, Yong Zheng

PMC · DOI: 10.3390/ijms27041844 · International Journal of Molecular Sciences · 2026-02-14

## TL;DR

This review summarizes advancements in methods for studying how proteins interact in cells, highlighting new techniques that capture dynamic interactions in real biological contexts.

## Contribution

The paper provides a comparative analysis of evolving PPI mapping methods and offers a practical framework for selecting appropriate techniques.

## Key findings

- First-generation methods like yeast two-hybrid and co-immunoprecipitation laid the groundwork for mapping static PPI networks.
- Second-generation techniques such as proximity labeling and advanced imaging allow for dynamic PPI analysis in native cellular environments.
- Emerging frontiers like spatial proteomics and single-cell interactomics are expected to further enhance our understanding of the interactome.

## Abstract

Protein–protein interactions (PPIs) are fundamental regulators of cellular function and disease. Systematic mapping of the interactome is essential for identifying therapeutic targets and advancing drug design, a pursuit that has driven significant innovation to capture the spatiotemporal regulation of PPIs in vivo. This review summarizes this methodological revolution. We outline foundational, first-generation techniques—yeast two-hybrid and co-immunoprecipitation—which established frameworks for binary interaction mapping and static network generation, especially when integrated with mass spectrometry. The discussion then pivots to second-generation methods, including proximity-dependent labeling and advanced imaging, which enable the capture of PPIs within their native, dynamic cellular contexts. We provide a comparative analysis of these techniques, detailing their principles, strengths, and limitations. The review concludes with a practical framework for method selection and a perspective on emerging frontiers—such as spatial proteomics and single-cell interactomics—that are poised to further decode the evolving interactome. This concise overview serves as a strategic guide for specialists adopting new techniques and a broader audience integrating network-level data into their research.

## Full-text entities

- **Genes:** Egfr (epidermal growth factor receptor) [NCBI Gene 13649] {aka 9030024J15Rik, Erbb, Errb1, Errp, Wa5, wa-2}, ANXA2 (annexin A2) [NCBI Gene 302] {aka ANX2, ANX2L4, CAL1H, HEL-S-270, LIP2, LPC2}, Trp53-ps (transformation related protein 53, pseudogene) [NCBI Gene 22060], SNCA (synuclein alpha) [NCBI Gene 6622] {aka NACP, PARK1, PARK4, PD1}, SHC1 (SHC adaptor protein 1) [NCBI Gene 6464] {aka SHC, SHCA}, Dlg4 (discs large MAGUK scaffold protein 4) [NCBI Gene 13385] {aka Dlgh4, PSD-95, PSD95, SAP90, SAP90A}, Egf (epidermal growth factor) [NCBI Gene 13645], PDCD1 (programmed cell death 1) [NCBI Gene 5133] {aka ADMIO4, AIMTBS, CD279, PD-1, PD1, SLEB2}, FOSB (FosB proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 2354] {aka AP-1, G0S3, GOS3, GOSB}, APEX2 (apurinic/apyrimidinic endodeoxyribonuclease 2) [NCBI Gene 27301] {aka APE2, APEXL2, XTH2, ZGRF2}, Grb2 (growth factor receptor bound protein 2) [NCBI Gene 14784] {aka Ash}, SLC7A11 (solute carrier family 7 member 11) [NCBI Gene 23657] {aka CCBR1, xCT}, USP10 (ubiquitin specific peptidase 10) [NCBI Gene 9100] {aka UBPO}, PHGDH (phosphoglycerate dehydrogenase) [NCBI Gene 26227] {aka 3-PGDH, 3PGDH, HEL-S-113, NLS, NLS1, PDG}, Mdm2 (MDM2 proto-oncogene) [NCBI Gene 17246] {aka 1700007J15Rik, Mdm-2}, PCBP2 (poly(rC) binding protein 2) [NCBI Gene 5094] {aka HNRNPE2, HNRPE2, hnRNP-E2}, NUP84 (Nup84p) [NCBI Gene 851441], EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, XYLT2 (xylosyltransferase 2) [NCBI Gene 64132] {aka PXYLT2, SOS, XT-II, XT2, xylT-II}, F2R (coagulation factor II thrombin receptor) [NCBI Gene 2149] {aka CF2R, HTR, PAR-1, PAR1, TR}, Erbb2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 13866] {aka Erbb-2, HER-2, HER2, Neu, c-erbB2, c-neu}, XAB2 (XPA binding protein 2) [NCBI Gene 56949] {aka HCNP, HCRN, NTC90, SYF1}, Bak1 (BCL2-antagonist/killer 1) [NCBI Gene 12018] {aka Bak, N-BAK1, N-Bak}, Bcl2 (B cell leukemia/lymphoma 2) [NCBI Gene 12043] {aka Bcl-2, C430015F12Rik, D630044D05Rik, D830018M01Rik}, Cd247 (CD247 antigen) [NCBI Gene 12503] {aka 4930549J05Rik, A430104F18Rik, Cd3, Cd3-eta, Cd3-zeta, Cd3h}, CFP (complement factor properdin) [NCBI Gene 5199] {aka BFD, PFC, PFD, PROPERDIN}
- **Diseases:** cancer (MESH:D009369), injury to (MESH:D014947), XL-MS (MESH:D009103), breast cancer (MESH:D001943), immune dysfunction (MESH:D007154), toxicity (MESH:D064420), colorectal cancer (MESH:D015179)
- **Chemicals:** biotin (MESH:D001710), Idasanutlin (MESH:C586849), SDS (MESH:D012967), oxaliplatin (MESH:D000077150), cAMP (MESH:D000242), BS3 (MESH:C035760), dimethyl adipimidate (MESH:D004119), peptides (MESH:D010455), Venetoclax (MESH:C579720), Milademetan (MESH:C000717787), glutaraldehyde (MESH:D005976), lysine (MESH:D008239), EDC (MESH:D005022), Cys (MESH:D003545), diazirine (MESH:D003978), pTyr (MESH:D019000), amino acid (MESH:D000596), Urea (MESH:D014508), amine (MESH:D000588), Disuccinimidyl suberate (MESH:C019358), Alexa Fluor 488 (MESH:C000711379), RG7112 (MESH:C579783), DSBU (-)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Bacillus subtilis (species) [taxon 1423], Zika virus (no rank) [taxon 64320], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** T24 — Homo sapiens (Human), Bladder carcinoma, Cancer cell line (CVCL_0554)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12940402/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940402/full.md

## References

113 references — full list in the complete paper: https://tomesphere.com/paper/PMC12940402/full.md

---
Source: https://tomesphere.com/paper/PMC12940402